Aarti Drugs announced that the United States Food and Drug Administration (USFDA) conducted an inspection at its active pharmaceutical ingredient (API) manufacturing facility located in MIDC, Tarapur, Maharashtra. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
